Thérapie par réalité virtuelle : Questions médicales fréquentes
Nom anglais: Virtual Reality Exposure Therapy
Descriptor UI:D063367
Tree Number:F04.754.137.506.662
Termes MeSH sélectionnés :
Surveys and Questionnaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thérapie par réalité virtuelle : Questions médicales les plus fréquentes",
"headline": "Thérapie par réalité virtuelle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thérapie par réalité virtuelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-10",
"dateModified": "2025-05-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thérapie par réalité virtuelle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Désensibilisation psychologique",
"url": "https://questionsmedicales.fr/mesh/D003887",
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation psychologique",
"code": {
"@type": "MedicalCode",
"code": "D003887",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par réalité virtuelle",
"alternateName": "Virtual Reality Exposure Therapy",
"code": {
"@type": "MedicalCode",
"code": "D063367",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Barbara O Rothbaum",
"url": "https://questionsmedicales.fr/author/Barbara%20O%20Rothbaum",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA."
}
},
{
"@type": "Person",
"name": "Per Carlbring",
"url": "https://questionsmedicales.fr/author/Per%20Carlbring",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychology, Stockholm University, Stockholm, Sweden."
}
},
{
"@type": "Person",
"name": "Triton Ong",
"url": "https://questionsmedicales.fr/author/Triton%20Ong",
"affiliation": {
"@type": "Organization",
"name": "Doxy.Me Research, Doxy.Me Inc, Rochester, NY, USA."
}
},
{
"@type": "Person",
"name": "Alexander Miloff",
"url": "https://questionsmedicales.fr/author/Alexander%20Miloff",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychology, Stockholm University, Stockholm, Sweden."
}
},
{
"@type": "Person",
"name": "Giuseppe Riva",
"url": "https://questionsmedicales.fr/author/Giuseppe%20Riva",
"affiliation": {
"@type": "Organization",
"name": "1 Applied Technology for Neuro-Psychology Lab, IRCCS Istituto Auxologico Italiano, Milan, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Current treatment status of IgA nephropathy in Japan: a questionnaire survey.",
"datePublished": "2023-08-30",
"url": "https://questionsmedicales.fr/article/37646957",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10157-023-02396-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Questionnaire survey of healthcare professionals on taxane-induced nail change in Japan.",
"datePublished": "2024-09-10",
"url": "https://questionsmedicales.fr/article/39251506",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00520-024-08858-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "[The Questionnaire Survey of Japanese Practice and Environment for Targeted Radionuclide Therapy in 2021].",
"datePublished": "2023-01-25",
"url": "https://questionsmedicales.fr/article/36696976",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.6009/jjrt.2023-1317"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sequential dependencies of responses in a questionnaire survey and their effects on the reliability and validity of measurement.",
"datePublished": "2022-09-09",
"url": "https://questionsmedicales.fr/article/36085546",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3758/s13428-022-01943-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Issues in the Adoption of Online Medical Care: Cross-Sectional Questionnaire Survey.",
"datePublished": "2024-11-01",
"url": "https://questionsmedicales.fr/article/39486019",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/64159"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines et activités comportementales",
"item": "https://questionsmedicales.fr/mesh/D004191"
},
{
"@type": "ListItem",
"position": 3,
"name": "Psychothérapie",
"item": "https://questionsmedicales.fr/mesh/D011613"
},
{
"@type": "ListItem",
"position": 4,
"name": "Thérapie comportementale",
"item": "https://questionsmedicales.fr/mesh/D001521"
},
{
"@type": "ListItem",
"position": 5,
"name": "Désensibilisation psychologique",
"item": "https://questionsmedicales.fr/mesh/D003887"
},
{
"@type": "ListItem",
"position": 6,
"name": "Thérapie par réalité virtuelle",
"item": "https://questionsmedicales.fr/mesh/D063367"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thérapie par réalité virtuelle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thérapie par réalité virtuelle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thérapie par réalité virtuelle",
"description": "Comment diagnostiquer une phobie ?\nQuels tests sont utilisés pour le PTSD ?\nLa réalité virtuelle est-elle un diagnostic ?\nQuels professionnels peuvent diagnostiquer ?\nQuels critères DSM sont utilisés ?",
"url": "https://questionsmedicales.fr/mesh/D063367?mesh_terms=Surveys+and+Questionnaires&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thérapie par réalité virtuelle",
"description": "Quels sont les symptômes de la phobie ?\nComment se manifeste le PTSD ?\nLa réalité virtuelle provoque-t-elle des symptômes ?\nQuels symptômes sont traités par la réalité virtuelle ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D063367?mesh_terms=Surveys+and+Questionnaires&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thérapie par réalité virtuelle",
"description": "Peut-on prévenir les phobies ?\nComment prévenir le PTSD après un traumatisme ?\nLa réalité virtuelle aide-t-elle à la prévention ?\nQuels conseils pour gérer l'anxiété ?\nLes groupes de soutien sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D063367?mesh_terms=Surveys+and+Questionnaires&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thérapie par réalité virtuelle",
"description": "Comment fonctionne la thérapie par réalité virtuelle ?\nQuels types de troubles sont traités ?\nCombien de séances sont nécessaires ?\nY a-t-il des effets secondaires ?\nLa thérapie est-elle personnalisable ?",
"url": "https://questionsmedicales.fr/mesh/D063367?mesh_terms=Surveys+and+Questionnaires&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thérapie par réalité virtuelle",
"description": "Quelles complications peuvent survenir ?\nLa thérapie peut-elle aggraver les symptômes ?\nY a-t-il des risques à long terme ?\nComment gérer les complications ?\nLes effets de la thérapie sont-ils durables ?",
"url": "https://questionsmedicales.fr/mesh/D063367?mesh_terms=Surveys+and+Questionnaires&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thérapie par réalité virtuelle",
"description": "Quels sont les facteurs de risque pour le PTSD ?\nLes phobies sont-elles héréditaires ?\nLe stress chronique influence-t-il les phobies ?\nLes traumatismes d'enfance sont-ils un facteur ?\nL'isolement social est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D063367?mesh_terms=Surveys+and+Questionnaires&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une phobie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic de phobie se fait par l'évaluation des symptômes et l'impact sur la vie quotidienne."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le PTSD ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires standardisés comme le PCL-5 aident à diagnostiquer le PTSD."
}
},
{
"@type": "Question",
"name": "La réalité virtuelle est-elle un diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, c'est une méthode de traitement, pas un diagnostic en soi."
}
},
{
"@type": "Question",
"name": "Quels professionnels peuvent diagnostiquer ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Psychologues, psychiatres et thérapeutes formés peuvent poser un diagnostic."
}
},
{
"@type": "Question",
"name": "Quels critères DSM sont utilisés ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères DSM-5 pour les phobies et le PTSD sont utilisés pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la phobie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'anxiété intense, la panique et l'évitement de la situation phobique."
}
},
{
"@type": "Question",
"name": "Comment se manifeste le PTSD ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le PTSD se manifeste par des flashbacks, des cauchemars et une hypervigilance."
}
},
{
"@type": "Question",
"name": "La réalité virtuelle provoque-t-elle des symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines personnes peuvent ressentir de l'anxiété ou du vertige lors de l'utilisation."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont traités par la réalité virtuelle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle traite principalement l'anxiété, les phobies et le PTSD."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'individu et de la gravité."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les phobies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une éducation précoce et une gestion du stress peuvent aider à prévenir les phobies."
}
},
{
"@type": "Question",
"name": "Comment prévenir le PTSD après un traumatisme ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un soutien psychologique immédiat et des interventions précoces peuvent réduire le risque."
}
},
{
"@type": "Question",
"name": "La réalité virtuelle aide-t-elle à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être utilisée pour préparer les individus à des situations stressantes."
}
},
{
"@type": "Question",
"name": "Quels conseils pour gérer l'anxiété ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de relaxation et de pleine conscience peuvent aider à gérer l'anxiété."
}
},
{
"@type": "Question",
"name": "Les groupes de soutien sont-ils utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes de soutien peuvent offrir un espace pour partager et apprendre."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la thérapie par réalité virtuelle ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle expose le patient à des environnements virtuels pour désensibiliser les peurs."
}
},
{
"@type": "Question",
"name": "Quels types de troubles sont traités ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est efficace pour les phobies, le PTSD et l'anxiété sociale."
}
},
{
"@type": "Question",
"name": "Combien de séances sont nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le nombre de séances varie, mais 6 à 12 sessions sont courantes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets comme le mal de tête ou la nausée peuvent survenir, mais sont rares."
}
},
{
"@type": "Question",
"name": "La thérapie est-elle personnalisable ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les environnements virtuels peuvent être adaptés aux besoins du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'aggravation de l'anxiété ou des réactions émotionnelles peuvent survenir."
}
},
{
"@type": "Question",
"name": "La thérapie peut-elle aggraver les symptômes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans de rares cas, elle peut intensifier les symptômes avant d'apporter des améliorations."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques à long terme sont faibles si la thérapie est bien encadrée par des professionnels."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier avec un thérapeute peut aider à gérer les complications."
}
},
{
"@type": "Question",
"name": "Les effets de la thérapie sont-ils durables ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets peuvent être durables, mais un suivi est souvent nécessaire pour maintenir les progrès."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour le PTSD ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des événements traumatisants et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Les phobies sont-elles héréditaires ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles anxieux peuvent augmenter le risque de phobies."
}
},
{
"@type": "Question",
"name": "Le stress chronique influence-t-il les phobies ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber les phobies et d'autres troubles anxieux."
}
},
{
"@type": "Question",
"name": "Les traumatismes d'enfance sont-ils un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes d'enfance augmentent le risque de développer des troubles anxieux."
}
},
{
"@type": "Question",
"name": "L'isolement social est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'isolement social peut augmenter le risque de troubles anxieux et de phobies."
}
}
]
}
]
}
In 2020, the Committee of Clinical Practical Guideline for IgA Nephropathy (IgAN) revised the clinical practice guidelines. Herein, we conducted a questionnaire survey to assess the potential discrepa...
A web-based survey of members of the Japanese Society of Nephrology was conducted between November 15 and December 28, 2021....
A total of 217 members (internal physicians: 203, pediatricians: 14) responded to the questionnaire. Of these respondents, 94.0% answered that the clinical practice guidelines were referred to "always...
Our questionnaire survey revealed real-world aspects of IgAN treatment in Japan....
Taxanes are widely used chemotherapeutic agents that frequently cause nail changes and have a significant impact on patients' quality of life. Despite the prevalence of taxane-induced nail toxicity, l...
The questions addressed prophylactic methods, evaluation practices, and treatment approaches for various nail disorders. The questionnaires were distributed on March 1, 2022, with a response deadline ...
Of the 120 questionnaires distributed, 88 (73.3%) were returned, and all of them were analyzed. The respondents included 69 physicians (32 oncologists, 26 breast surgeons, 6 dermatologists, 3 obstetri...
Our survey revealed that the management of chemotherapy-induced nail changes varies in clinical practice in Japan. These findings emphasize the need for standardized management strategies and further ...
Recently, the targeted radionuclide therapy (TRT) was urgently required to adapt the practice and environment because of the implementation of novel therapeutic radiopharmaceuticals such as alpha- and...
The massive questionnaire survey, 2 months from October to November 2021, was conducted among nationwide 251 facilities that have performed TRT in the past two years. The alpha- and beta- therapeutic ...
The survey response rate was 69.1% (174 facilities). About 75% of these facilities reported that they either follow the guidelines or take their own measures to reduce occupational exposure. The confi...
We clarified the Japanese problem for TRT practice and environment by the questionnaire survey. Our findings indicated that the Japanese guidelines and manuals for TRT were not partly followed in the ...
The reliability and validity of measurements in questionnaire surveys are affected by the survey design. Previous studies have discussed whether the items on a multidimensional scale should be grouped...
Telemedicine, or online medical care, has gained considerable attention worldwide. However, it has not been widely adopted in Japan, and the detailed status of received and provided online medical car...
This study aims to investigate the current status of online medical care in Japan and the factors limiting its adoption from the perspective of both patients receiving and medical professionals provid...
In total, 2 nationwide questionnaire surveys were conducted. The first survey, targeting both patients and healthy individuals, screened approximately 40,000 participants among 13 million people. The ...
The response rates among patients and healthy individuals targeted for the screening and main surveys were 92.5% (36,998/40,000) and ˃80% (1312/1478, 88.77%; 1281/1522, 84.17%; 404/478, 84.5%; and 222...
Our nationwide surveys provided insights into the current status of online medical care in Japan and simultaneously identified several problems and issues related to it, which will be useful in promot...
Despite the growing understanding of the carcinogenesis of pelvic high-grade serous carcinoma (HGSC) of the ovary and peritoneum and its precursor lesion serous tubal intraepithelial carcinoma (STIC),...
A questionnaire containing 21 questions was developed to explore the clinical experience with patients with the diagnosis of STICs and the diagnostic, surgical and histopathological approaches in Germ...
131 questionnaires (response rate 24.3%) were included in this survey. 45.8% of the respondents had treated one to three STIC patients during their career. 75.6% of the respondents performed opportuni...
Our survey highlights significant inconsistency in the management of patients with STIC. Prospective data are urgently needed to elucidate the clinical impact of a STIC lesion and its clinical managem...
Management of a clinical condition is patient centric. Interdisciplinary coordination plays an influential role in patient management. Pharmacology deals with the study of drugs. Clinical pharmacology...
We set up a survey to assess the perceptions of clinical pharmacologists (CPs) regarding their roles and about clinical pharmacology courses in India. The survey was administered via a Google question...
Respondents to the questionnaire were working as CPs. They were either postgraduate in pharmacology (MD pharmacology (doctor of medicine in pharmacology) 60.2%) or had a super-specialization degree in...
All the CPs opined that training during the postgraduation course was not sufficient to be qualified as CP. There was no consensus among the CPs on the benefit of existing certification courses in cli...
Response to survey questionnaires is vital for social and behavioural research, and most analyses assume full and accurate response by participants. However, nonresponse is common and impedes proper i...
To describe psychometric validation of the newly developed Advanced Practice Nurse Task Questionnaire....
Cross-sectional quantitative study....
The development of the questionnaire followed an adapted version of the seven steps described in the guide by the Association for Medical Education in Europe. A nationwide online survey tested the con...
We received 222 questionnaires between January and September 2020. The factor analysis produced a seven-factor solution as suggested in Hamric's model. However, not all item loadings aligned with the ...
A precise assessment of advanced practice nurse tasks is crucial in clinical practice and in research as it may be a basis for further refinement, implementation and evaluation of roles....
The Advanced Practice Nurse Task Questionnaire is the first valid tool to assess tasks according to Hamric's model of competencies independently of the role or the setting. Additionally, it distinguis...
The STARD 2015 guideline was used to report the study....
No patient or public contribution....
Chronic diseases are characterized by high incidence, long-term medication, and complex types of medication. There are also many corresponding medication therapy management (MTM) applications on the m...
From August 2019 to December 2019, we created a questionnaire to have knowledge of user needs, preferences, and expectations for MTM applications among 302 chronic patients in Hunan, Guangdong, and ot...
A total of 260 (86.09%) out of 302 patients the respondents were willing to use the MTM applications of chronic disease. The independent influencing factors for using the MTM applications were long-te...
The participants are willing to use MTM applications of chronic disease, with a preference for the WeChat applet. Patients tended to use MTM applications if they had a long-term medication history or ...